loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r2_cep_1995_006___rev_05 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Lonza Group

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Lonza Braine S.A. Braine-L'Alleud BE (1)

    filter

    01 Desmopressin, Solid phase synthesis process (1)

    filter

    01 Switzerland (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Lonza Braine S.A. Braine-L'Alleud B...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Desmopressin, Solid phase synthesis process

    PDF Supplier PDF
    URL Supplier Web Content
    R2-CEP 1995-006 - Rev 05
    Withdrawn by Holder
    Chemical
    2011-04-29
    2013-07-03
    712
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R2-CEP 1995-006 - Rev 05 of Lonza Braine S.a. Braine-l'alleud Be

    Looking for Certificates of Suitability (CEPs) for R2-CEP 1995-006 - Rev 05 of Lonza Braine S.a. Braine-l'alleud Be 1

    20

    Lonza Braine S.a. Braine-l'alleud Be, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Desmopressin, Solid phase synthesis process, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R2-CEP 1995-006 - Rev 05

    This Chemical Type CEP, issued on April 29, 2011, remains in force until July 03, 2013, ensuring its reliability within the pharmaceutical industry.

    Substance Number 712 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY